289
Participants
Start Date
July 25, 2018
Primary Completion Date
January 15, 2021
Study Completion Date
October 1, 2027
Incidental Genomic Sequencing Results
"Patient will receive GS results related to their primary indication (cancer), as well as the option to learn incidental GS results. Incidental results will be categorized into five bins based on Berg et al.'s framework (medically actionable and pharmacogenetic, common disease SNPs, Mendelian conditions, early-onset brain diseases, and carrier status). In pre-test counseling, patients will have the option to select which bins of incidental results they would like to learn, if any."
GS Results for Primary Indications only
Patients will receive GS results related to the primary indication (cancer) only.
Mount Sinai Hospital, Toronto
Princess Margret Cancer Centre, Toronto
Sunnybrook Hospital, Toronto
Unity Health Toronto
OTHER